Skip to content
Open access

Biological and genomic characterization of Escherichia phage KBU_SV1 active against carbapenem-resistant Escherichia coli

Oct 2026 · Frontiers in Microbiology · Vol 17 · 0 citations · 62 references
Medicine

TL;DR

Escherichia phage KBU_SV1 has favorable properties such as antibacterial potential against carbapenem-resistant E. coli, broad stability, antibiofilm and in vivo activity, and the absence of virulence and AMR genes.

Abstract

Carbapenem-resistant Escherichia coli infections are increasingly difficult to treat, and bacteriophages have been highlighted as a promising tool to control such multidrug-resistant bacteria. Here, we isolated and characterized Escherichia phage KBU_SV1 using E. coli ATCC 25922 as the isolation and propagation host. Its morphology, host range, stability at various temperatures and pH, reduction growth of bacteria, effect on biofilm, in vivo efficacy, and genome were investigated. Transmission electron microscopy showed a polyhedral head and a long, non-contractile tail, corresponding to a siphovirus morphotype. The spot-test analysis of 106 bacterial strains showed spot clearance against 16 strains (host range index, 0.15), including carbapenem-resistant and carbapenem-susceptible E. coli isolates and, to a lesser extent, Klebsiella pneumoniae, while no such effect was observed in the other species tested. KBU_SV1 was stable between pH 4 and 12 and at 4–37 °C, but no infectivity was detected at pH 2 or 65 °C. Bacterial growth was suppressed at all multiplicities of infection (MOI) tested (100–0.01), followed by gradual regrowth. KBU_SV1 reduced established biofilms and inhibited biofilm formation in both E. coli ATCC 25922 and the carbapenem-resistant isolate Ec59. In the Galleria mellonella infection model, phage treatment significantly delayed larval mortality compared with the infection control, while no mortality occurred in larvae receiving phage alone. The genome of KBU_SV1 was found to be 45,190 bp with a G + C content of 53.56% and was complete with a 272-bp direct terminal repeat. The genome contains 71 putative open reading frames (ORFs) and no tRNA, while no virulence, antibiotic resistance (AMR) or lysogeny-associated genes were identified, and genome-based analyses predicted a virulent lifestyle. Comparative genomic analysis showed a high nucleotide identity (99.12%) with Escherichia phage EPIMAM03, and KBU_SV1 was assigned to the genus Dhillonvirus within the class Caudoviricetes. All these results showed that KBU_SV1 has favorable properties such as antibacterial potential against carbapenem-resistant E. coli, broad stability, antibiofilm and in vivo activity, and the absence of virulence and AMR genes. Based on all these features, this newly isolated phage is promising for the control of carbapenem-resistant E. coli infections, alone or in phage cocktails.

Read PDF

Similar papers

Open access Sep 2026

Genomic Characterization of 30 Lytic Klebsiella pneumoniae Bacteriophages

A collection of candidate phages for further development as potential antimicrobial agents against CR-KP are described and the complexity in understanding phage–host dynamics of phages that recognize non-capsule receptors in K. pneumoniae is described.

Daniel Mora, Trisha Gryder, L. Lessor et al. · 0 citations
Open access Oct 2026

Spontaneous wbbL and waaG mutations selected by phage vB_EcoP_P61425 confer resistance and attenuate virulence in ExPEC

Bacteriophage therapy is a promising strategy against multidrug-resistant (MDR) extraintestinal pathogenic Escherichia coli (ExPEC), yet bacterial resistance evolution remains a major clinical challenge. In this study, we isolated and comprehensively characterized a novel lytic phage, vB_EcoP_P61425, belonging to the g...

Long Chen, Si-Xiang Xu, Xiao-Yue Li et al. · 0 citations
Nov 2026

Isolation, characterization, and therapeutic potential of a novel phage vB_KpiP_JZBo1 infecting Klebsiella pneumoniae.

Klebsiella pneumoniae (K. pneumoniae) is an important opportunistic pathogenic bacterium that is often characterized by a multidrug-resistant phenotype, which can lead to the failure of antibiotic treatments. The emergence of multidrug-resistant K. pneumoniae, including carbapenem-resistant K. pneumoniae (CRKP), poses...

Dai Peng, Rui Cao, Xiang Sun et al. · 0 citations
Open access 2026

Isolation and genomic characterization of drug-resistant Pseudomonas aeruginosa and its phage from Iraqi hospital wastewater

Pseudomonas aeruginosa can develop resistance to antibiotics and tolerance to antimicrobials. Bacteriophages have been proposed as an alternative strategy for eliminating pathogens, but they require further genetic studies. Therefore, this study aimed to isolate a bacteriophage from hospital wastewater, examine its bio...

B. Abdulsattar, Abdulrahman A. Abdulhussein, Jaleel N. Samanje et al. · 0 citations
Oct 2026

Isolation and Genomic Characterization of a Lytic Salmonella enterica Serovar Typhimurium Bacteriophage (S2EK)

Background: Salmonella enterica serovar Typhimurium is a foodborne pathogen, and lytic phages may provide targeted biocontrol. Materials and Methods: S2EK was evaluated for host range, replication, broth growth suppression, stability, and genome characteristics. Results: S2EK lysed its isolation host but did not lyse t...

K. Yıldırım, Aleyna Kavalcı, Emel Cengiz Kaynakcı · 0 citations
Open access Sep 2026

Phenotypic Characterization and Preliminary In Vivo Evaluation of a Locally Isolated Klebsiella pneumoniae Bacteriophage

The phage merits further study, but whole-genome sequencing, confirmation of the host species, host-range testing against diverse clinical isolates and a controlled comparison with antibiotic treatment are all needed before any therapeutic claim can be made.

M. Sarmykova, A. Abdykalyk, N. Syrym et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.